Genmab A/S (GMAB) is catching the attention of investors following a recent upgrade to a Buy rating by Yaron Werber of TD ...

On July 23, 2026, analysts from Wolfe Research upgraded AT&T Inc. (T) to an “Outperform” rating, reflecting a positive shift ...

In a notable shift, Morgan Stanley analyst Ronald Kamdem downgraded Vornado Realty Trust (NYSE: VNO) to an “Underweight” ...

Utz Brands, Inc. (NYSE: UTZ) recently found itself in the spotlight following an Equal-Weight rating assigned by Andrew Lazar of Barclays on July 21, 2026. The rating indicates a tempered outlook for ...

John Janedis is an analyst from Wolfe Research specializing in the Communication Services sector. They are beginning to establish their track record, with 1 stock rating so far. Their current stats ...

On July 13, 2026, Andrew Kligerman of TD Cowen assigned a “Sell” rating to The Travelers Companies, Inc. (NYSE: TRV), ...

WESCO International, Inc. (WCC) has received an upgraded rating from Tommy Moll at Stephens & Co., shifting from a neutral ...

Voyager Technologies, Inc. (NASDAQ: VOYG) has recently experienced a significant shift in analyst sentiment, as Kristine ...

Joseph Civello is an analyst from Truist Securities specializing in the Consumer Cyclical sector. Ranked #2314 out of 4742 analysts, they have issued 38 stock ratings with a success rate of 76.70% and ...

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational ...

According to analyst ratings and projections for AEON, AEON Biopharma, Inc. shares are anticipated to decrease by -2.30%, potentially reaching $0.25 per share by August 6, 2026. Short-term technical ...

Paul Johnson is an analyst from Keefe, Bruyette & Woods Ranked #1172 out of 4742 analysts, they have issued 51 stock ratings with a success rate of 100.00% and an average return of 8.97%. Paul Johnson ...